BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 15529579)

  • 1. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
    Cojocaru IM; Cojocaru M; Muşuroi C
    Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum anti-titin antibody in patients with myasthenia gravis].
    Li YF; Zhang JB; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
    Peers J; McDonald BL; Dawkins RL
    Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunofluorescence studies in myasthenia].
    Slomkowska H
    Neurol Neurochir Pol; 1972; 6(2):205-10. PubMed ID: 4555306
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.
    Bagnato F; Clemenzi A; Scagnolari C; Strizzi L; Di Pasquale A; Bellomi F; Di Marco P; Antonelli G; Antonini G
    Eur Cytokine Netw; 2004; 15(1):24-9. PubMed ID: 15217749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis-associated antibodies in asymptomatic thymoma.
    Moore HJ; Woods EL
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):308-10. PubMed ID: 3968916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myasthenia gravis associated with carcinoma of the thymus. A report of three cases].
    Viéitez MC; Aladró Y; Alemany MJ; Amela R; Muñoz C; Santana N
    Rev Neurol; 2001 Jun 16-30; 32(12):1135-7. PubMed ID: 11562844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of allergic conjunctivitis in myasthenia gravis without thymoma.
    Murai H; Osoegawa M; Ochi H; Kira J
    J Neurol Sci; 2004 Oct; 225(1-2):27-31. PubMed ID: 15465082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
    Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
    Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma.
    Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S
    J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striational antibodies in a paraneoplastic context.
    McKeon A; Lennon VA; LaChance DH; Klein CJ; Pittock SJ
    Muscle Nerve; 2013 Apr; 47(4):585-7. PubMed ID: 23463255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.